PUNE, India, January 4, 2018 /PRNewswire/ —
According to a new market research “Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) – Global Forecast to 2022“, published by MarketsandMarkets™, the market is expected to reach USD 12.63 Billion by 2022 from USD 9.09 Billion in 2017, at a CAGR of 6.8%. Factors driving the growth of this market include technological advancements in Peripheral Vascular Devices, rising geriatric population, increasing incidence of aneurysm cases, and increasing preference for minimally invasive surgeries.
Browse 217 market data Tables and 33 Figures spread through 200 Pages and in-depth TOC on “Peripheral Vascular Devices Market“
Early buyers will receive 10% customization on this report
Angioplasty stents are estimated to account for the largest share of the Peripheral Vascular Devices Market in 2017.
The Peripheral Vascular Devices include angioplasty stents, angioplasty balloons, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, hemodynamic flow alteration devices, and other devices. In 2017, the angioplasty stents segment is expected to hold the largest share of the market. Angioplasty stents are further segmented into bare-metal stents and drug-eluting stents. The drug-eluting stents segment is expected to account for the largest share of the global Peripheral Vascular Devices Market in 2017. Factors driving the growth of this subsegment are the wide range of benefits associated with the use of drug-eluting stents and the widespread availability of these devices across the globe.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=790
The hemodynamic flow alteration devices market is estimated to grow at the highest CAGR during the forecast period.
Hemodynamic flow alteration devices are further segmented into embolic protection devices and chronic total occlusion devices. The embolic protection devices segment is expected to account for the largest share of the global Peripheral Vascular Devices Market in 2017. Market growth can largely be attributed the increasing number of endovascular surgeries, investments for new technology development, and regulatory approvals for these devices.
North America is expected to command the largest share of the market during the forecast period.
Based on region, the Peripheral Vascular Devices Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is estimated to dominate the Peripheral Vascular Devices Market in 2017. This is mainly due to factors such as the rising incidence of cardiovascular diseases, growing geriatric population, and the strong presence of industry players in the region.
Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=790
Key players in the Peripheral Vascular Devices Market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and Biotronik (Germany).
Browse Related Reports:
Vascular Stent Market by Type (BMS, BVS, Drug Eluting), Product (Coronary, Peripheral, Carotid, Femoral, Aortic Aneurysm), Material [Metal (Stainless Steel, PtCr, Nitinol), Polymer], End User (Hospital, Cardiology Center, ASC)- Global Forecast to 2021
https://www.marketsandmarkets.com/Market-Reports/vascular-stent-market-199869009.html
Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) – Global Forecasts to 2022
https://www.marketsandmarkets.com/Market-Reports/thrombectomy-devices-market-222966801.html
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
SOURCE MarketsandMarkets
